Cargando…
Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
BACKGROUND & AIMS: Population screening for non-alcoholic fatty liver disease (NAFLD) and associated comorbidities remains an unaddressed clinical need. We aimed to assess the utility of the fatty liver index (FLI) for risk stratification of NAFLD and related comorbidities using the UK Biobank....
Autores principales: | Ho, Brian, Thompson, Andrew, Jorgensen, Andrea L, Pirmohamed, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624587/ https://www.ncbi.nlm.nih.gov/pubmed/37928746 http://dx.doi.org/10.1016/j.jhepr.2023.100896 |
Ejemplares similares
-
Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023) -
Comorbidities and Outcomes among Females with Non-Alcoholic Fatty Liver Disease Compared to Males
por: Abu-Freha, Naim, et al.
Publicado: (2022) -
Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
por: Sinha, Rohit, et al.
Publicado: (2020) -
Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022) -
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)